Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sarcospan is a 25 kDa integral transmembrane protein with four predicted transmembrane domains and tetraspanin-like structure, essential for forming and stabilizing the dystrophin-glycoprotein complex at the muscle cell membrane[1][2][3][5]. It tightly associates with sarcoglycans and facilitates their clustering, linking cellular cytoskeleton to the extracellular matrix[1][2][3][5]. Sarcospan is critical for skeletal muscle integrity; its deficiency results in impaired membrane stability, defective cell adhesion, and compromised muscle regeneration[1][2][3]. Overexpression of sarcospan has therapeutic potential in models of Duchenne muscular dystrophy, as it promotes membrane stability, enhances the surface presence of compensatory adhesion complexes, and facilitates Akt-driven muscle regeneration[1][4]. Mutations affecting sarcospan or its interacting partners can result in muscular dystrophy, notably autosomal recessive limb-girdle muscular dystrophy[2][3]. Sarcospan participates in the formation of membrane scaffolds that anchor key adhesion complexes and protect muscle fibers from contraction-induced damage[3][5].
Stabilization and remodeling of membrane adhesion complexes to link extracellular matrix to intracellular cytoskeleton; Regulation of protein abundance (utrophin, α7β1 integrin, dystrophin); Activation/modulation of Akt signaling pathways for muscle regeneration; Scaffolding and stabilization of DGC to prevent membrane damage
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sarcospan (SSPN).